{"nct_id":"NCT02675452","title":"AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia","status":"TERMINATED","status_verified_date":"2025-06","start_date":"2016-06-13","start_date_type":"ACTUAL","primary_completion_date":"2024-05-27","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}